iopromide has been researched along with Hyperplasia in 3 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clauss, W | 1 |
| Scheller, B | 1 |
| Schmitt, A | 1 |
| Sovak, M | 1 |
| Speck, U | 1 |
| Watson, TD | 1 |
| Patel, SJ | 1 |
| Nardi, PM | 1 |
| Chong, VF | 1 |
| Fan, YF | 1 |
| Khoo, JB | 1 |
1 trial available for iopromide and Hyperplasia
| Article | Year |
|---|---|
No difference among modern contrast media's effect on neointimal proliferation and restenosis after coronary stenting in pigs.
Topics: Angioplasty, Balloon, Coronary; Animals; Contrast Media; Coronary Vessels; Graft Occlusion, Vascular | 2003 |
2 other studies available for iopromide and Hyperplasia
| Article | Year |
|---|---|
Case 121: familial adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing syndrome.
Topics: Adrenal Cortex; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Contrast Media; Cushing Syndrome | 2007 |
Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma.
Topics: Carcinoma; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Hyperplasia; Image Enhancement; Iohe | 1995 |